You are here

Press Releases

Press Release | December 10, 2019

Washington, D.C. – The Advanced Medical Technology Association (AdvaMed) today issued the following statement from President and CEO Scott Whitaker on the newly upgraded United States-Mexico-Canada Agreement (USMCA):

Press Release | December 10, 2019

WASHINGTON, D.C. – The Medical Alley Association yesterday released a survey of its membership demonstrating that if the medical device tax is reinstated on Jan. 1, 2020, 83 percent of medtech companies will decrease R&D spending, 67 percent will delay or forego planned hiring, and 47 percent will delay plans to physically expand their business.

Press Release | December 9, 2019

WASHINGTON, D.C. – More than 1,000 medical technology companies started after the device tax was last in effect (from 2013-15) will pay the excise tax for the first time in January if Congress fails to repeal or delay the tax, according to an AdvaMed analysis of the industry. 

Press Release | December 6, 2019

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) released the following statement from President and CEO of AdvaMed Scott Whitaker on today's November jobs report by the U.S. Dept. of Labor:

Press Release | December 6, 2019

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on the introduction of legislation in the U.S. House by Reps. Suzan DelBene (D-Wash.), Jackie Walorski (R-Ind.), Tony Cardenas (D-Calif.), Gus Bilirakis (R-Fla.), Roger Marshall (R-Kan.), and Terri Sewell (D-Ala.) to streamline Medicare coverage and reimbursement processes for innovative medical technologies: 

Press Release | December 3, 2019
Mark Brager
mbrager@advamed.org

WASHINGTON, D.C. – A new analysis released today by the nonpartisan Tax Foundation reports that the return of the medical device excise tax would lead to a loss of 21,390 U.S. medical technology jobs and a $1.74 billion decline in the nation’s GDP. 

Press Release | November 21, 2019

WASHINGTON, D.C. – A coalition of major U.S. business groups is calling on Congress to repeal the medical device excise tax before it comes back into effect at the end of this year, triggering a $20 billion tax increase on the medical technology industry.

Press Release | November 20, 2019

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on the introduction of legislation in the U.S. Senate by Sens. Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.) to improve Medicare beneficiaries’ access to innovative diabetes management technologies:

Press Release | November 12, 2019

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) is launching a suite of tools and resources – including online training, credentialing and certification – to aid implementation of its updated Code of Ethics on Interactions with Health Care Professionals (HCPs) in the U.S. The revised code, which was unveiled in January 2019 and becomes effective on Jan. 1, 2020, reflects evolving legal standards, care delivery models and best practices over the last decade.

Press Release | November 12, 2019

WASHINGTON, D.C. – As Congress prepares to address end-of-year spending decisions and other initiatives that are set to expire if not acted upon, the Advanced Medical Technology Association (AdvaMed) today released survey results showing that reinstatement of the medical device excise tax would bring job losses as well as declines in investment in research and development.

Pages